Literature DB >> 19442203

Researches toward potassium channels on tumor progressions.

Zheng Shen1, Qian Yang, Qidong You.   

Abstract

As trans-membrane proteins located in cytoplasm and organelle membrane, potassium (K(+)) channels are generally divided into four super-families: voltage-gated K(+) channels (K(v)), Ca(2+)-activated K(+) channels (K(Ca)), inwardly rectifying K(+) channels (K(ir)) and two-pore domain K(+) channels (K(2P)). Since dysfunctions of K(+) channels would induce many diseases, various studies toward their functions in physiologic and pathologic process have been extensively launched. This review focuses on the recent advances of K(+) channels in tumor progression, including the brief introduction of K(+) channels, the role of K(+) channels in tumor cells, the possible mechanism of action at cellular level, and the possible application of K(+) channel modulators in cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442203     DOI: 10.2174/156802609788317874

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

1.  The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells.

Authors:  Claudia P Alvarez-Baron; Philip Jonsson; Christoforos Thomas; Stuart E Dryer; Cecilia Williams
Journal:  Mol Endocrinol       Date:  2011-06-16

2.  Impact of NPR-A expression in gastric cancer cells.

Authors:  Jia Zhang; Jingkun Qu; Ya Yang; Min Li; Mingxin Zhang; Xiaohai Cui; Jing Zhang; Jiansheng Wang
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 3.  Potassium Channels as a Target for Cancer Therapy: Current Perspectives.

Authors:  Leandro Zúñiga; Angel Cayo; Wendy González; Cristian Vilos; Rafael Zúñiga
Journal:  Onco Targets Ther       Date:  2022-07-20       Impact factor: 4.345

4.  Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.

Authors:  S Rezania; S Kammerer; C Li; B Steinecker-Frohnwieser; A Gorischek; T T J DeVaney; S Verheyen; C A Passegger; N Ghaffari Tabrizi-Wizsy; H Hackl; D Platzer; A H Zarnani; E Malle; S W Jahn; T Bauernhofer; W Schreibmayer
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.